Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

SUPERNUS PHARMACEUTICALS, INC. (SUPN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

SUPERNUS PHARMACEUTICALS, INC. (SUPN), most recent 12 months reported: revenue $830.44M, net loss $109.89M, free cash flow $18.79M. Latest balance sheet on file: liquid cash $372.07M. From SEC filings. Others in Pharmaceutical Preparations: ANI PHARMACEUTICALS, INC · HARMONY BIOSCIENCES HOLDINGS, INC. · Ionis Pharmaceuticals, Inc. · CORCEPT THERAPEUTICS INC · Collegium Pharmaceutical, Inc. · TG THERAPEUTICS, INC. · AXSOME THERAPEUTICS, INC. · EMERGENT BIOSOLUTIONS INC.

Stock screener

Watchlist